Shuting Li

Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors

Yongkun Sun, Wei Niu, Feng Du et al. · Journal of Hematology & Oncology · 2016 · 431 citations · Full text

Medicine, Oncology, Pharmacology +15

Clinical analysis and prognosis of synchronous and metachronous multiple primary malignant tumors

Meng Lv, Xiao Zhang, Yanwei Shen et al. · Medicine · 2017 · 153 citations · Full text

Veterinary Medicine, Oncology, Pathology +12

Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990–2019: an age-period-cohort analysis for the global burden of disease 2019 study

Zheng Lou, Yizhou Huang, Shuting Li et al. · BMC Public Health · 2023 · 75 citations · Full text

Veterinary Medicine, Gynecology, Health Sciences +17

Association Between Four Anthropometric Indexes and Metabolic Syndrome in US Adults

Yaling Li, Rui Zheng, Shuting Li et al. · Frontiers in Endocrinology · 2022 · 73 citations · Full text

Education, Biostatistics, Clinical Nutrition +14

The longitudinal effect of the atherogenic index of plasma on type 2 diabetes in middle-aged and older Chinese

Yi Qian, Ziyang Ren, Guannan Bai et al. · Acta Diabetologica · 2021 · 72 citations

Medicine, Endocrinology, Geriatric Medicine +11